Avandamet
Links shared publicly online about this topic
Rosiglitazone maleate (marketed as Avandia, Avandamet, and Avandaryl) Information
fda.gov — “Rosiglitazone maleate (marketed as Avandia, Avandamet, and Avandaryl) Information” View full resource at fda.gov
Most Recently Shared on February 22, 2010 at 7:46 pm By:
eyeonfda Pharma and Health Lawyer
RT @mhuckman: New FDA communication (just posted) on Avandia. $GSK http://tinyurl.com/pmfdaava
European Medicines Agency Recommends Suspension Of Avandia, Avandamet And Avaglim
medicalnewstoday.com — “The European Medicines Agency recommended the suspension of the marketing authorisations for the rosiglitazone-containing anti-diabetes medicines Avandia, Avandamet and Avaglim. These medicines wi” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2010 at 2:05 pm By:
MNT Drug Approvals Health News
European Medicines Agency Recommends Suspension Of Avandia, Avandamet And Avaglim http://mnt.to/3Kg7 #regulatory
Avandia, Avandamet, and Avandaryl to be Removed from Retail Pharmacies - ONA
oncologynurseadvisor.com — “The FDA announced that after November 18, 2011, the diabetes drugs, Avandia (rosiglitazone), Avandamet (rosiglitazone/metformin), and Avandaryl (rosiglitazone/glimepiride) will be withdrawn from retail pharmacies by GlaxoSmithKline.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 19, 2011 at 7:39 pm By:
OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology
Avandia, Avandamet, and Avandaryl to be Removed from Retail Pharmacies http://goo.gl/fb/fVjBp
Avandia, Avandamet, and Avandaryl to be Removed from Retail Pharmacies - MPR
empr.com — “The FDA announced that after November 18, 2011, the diabetes drugs, Avandia (rosiglitazone), Avandamet (rosiglitazone/metformin), and Avandaryl (rosiglitazone/glimepiride) will be withdrawn from retail pharmacies by GlaxoSmithKline.” View full resource at empr.com
Most Recently Shared on May 19, 2011 at 7:43 pm By:
MPR News: Avandia, Avandamet, and Avandaryl to be Removed from Retail Pharmacies: The FDA announced that after N... http://bit.ly/iVU0KT
European Medicines Agency recommends suspension of Avandia, Avandamet and Avaglim - Drugs.com MedNews
drugs.com — “Anti-diabetes medication to be taken off the market LONDON, Sept. 23, 2010-The European Medicines Agency today recommended the suspension of the marketing autho” View full resource at drugs.com
Most Recently Shared on September 23, 2010 at 5:15 pm By:
Drugs and Devices OW OW Health
European Medicines Agency recommends suspension of Avandia, Avandamet and Avaglim: Anti-diabetes medication t... http://bit.ly/bklh5o #drug
European Medicines Agency Update On Ongoing Benefit-Risk Review Of Avandia, Avandamet And Avaglim
medicalnewstoday.com — “The European Medicines Agency is currently reviewing rosiglitazone to determine the impact of new data, from recent publications on the risk of cardiovascular problems, on the benefit- risk profil” View full resource at medicalnewstoday.com
Most Recently Shared on July 23, 2010 at 3:06 pm By:
MNT Cardiovascular Health News
European Medicines Agency Update On Ongoing Benefit-Risk Review Of Avandia, Avandamet And Avaglim http://mnt.to/3GtX #cardiovascular
Diabetes Drugs Avandia, Avandamet, and Avandaryl To Exit Retail Pharmacies « WebMD Newsroom
blogs.webmd.com — “WebMD's editorial staff on the latest news from the world of health.” View full resource at blogs.webmd.com
Most Recently Shared on May 23, 2011 at 2:37 pm By:
Diabetes Drugs Avandia, Avandamet, and Avandaryl To Exit Retail Pharmacies http://bit.ly/iElYxv
Diabetes Drugs Avandia, Avandamet, and Avandaryl To Exit Retail Pharmacies « WebMD Newsroom
blogs.webmd.com — “WebMD's editorial staff on the latest news from the world of health.” View full resource at blogs.webmd.com
Most Recently Shared on May 19, 2011 at 4:52 pm By:
WebMD News: Diabetes Drugs Avandia, Avandamet, and Avandaryl To Exit Retail Pharmacies http://dlvr.it/SGk4J
Diabetes Drugs Avandia, Avandamet, and Avandaryl To Exit Retail Pharmacies « WebMD Newsroom
blogs.webmd.com — “WebMD's editorial staff on the latest news from the world of health.” View full resource at blogs.webmd.com
Most Recently Shared on May 19, 2011 at 4:51 pm By:
Andi Gabrick, WebMD Health Magazine
Diabetes Drugs Avandia, Avandamet, and Avandaryl To Exit Retail Pharmacies: Starting in November... http://bit.ly/j0tmuq via @WebMD_News
PharmaLive: European Medicines Agency recommends suspension of Avandia, Avandamet and Avaglim
pharmalive.com — “PharmaLive: European Medicines Agency recommends suspension of Avandia, Avandamet and Avaglim” View full resource at pharmalive.com
Most Recently Shared on September 23, 2010 at 4:13 pm By:
PharmaLive Pharma and Health News
EMA Recommends Suspension of Avandia - http://tinyurl.com/3y629x9
FDA Drug Safety Communication: Updated Risk Evaluation and Mitigation Strategy (REMS) to Restrict Access to Rosiglitazone-containing Medicines including Avandia, Avandamet, and Avandaryl
fda.gov — “The U.S. Food and Drug Administration (FDA) is informing the public of new restrictions to the prescribing and use of rosiglitazone-containing medicines.” View full resource at fda.gov
Most Recently Shared on May 18, 2011 at 6:06 pm By:
Updated Risk Evaluation & Mitigation Strategy to Restrict Access to Rosiglitazone-containing Medicines (FDA) http://1.usa.gov/lwECEi
A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Typ
onlinelibrary.wiley.com — “A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Type 2 Diabetes Mellitus Patients. - Borges - Diabetes, Obesity and Metabolism - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on June 19, 2011 at 8:19 am By:
A Randomized, Parallel Group, Doubleâ€*blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (... http://bit.ly/lDWJXI
A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Typ
onlinelibrary.wiley.com — “A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Type 2 Diabetes Mellitus Patients. - Borges - Diabetes, Obesity and Metabolism - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on June 19, 2011 at 8:20 am By:
A Randomized, Parallel Group, Doubleâ€*blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (... http://bit.ly/kxWgY1
A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Typ
onlinelibrary.wiley.com — “A Randomized, Parallel Group, Double-blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (Rosiglitazone/Metformin) and Metformin on Long-term Glycaemic Control and Bone Mineral Density after 80 Weeks of Treatment in Drug-naïve Type 2 Diabetes Mellitus Patients. - Borges - Diabetes, Obesity and Metabolism - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on June 18, 2011 at 8:41 pm By:
Endocrinology Wisdom OW Health
A Randomized, Parallel Group, Doubleâ€*blind, Multicentre Study Comparing the Efficacy and Safety of Avandamet (... http://bit.ly/iAAVeh
CHMP Meets To Discuss Avandia And Pandemrix, Europe
medicalnewstoday.com — “The Committee for Medicinal Products for Human Use (CHMP) met on Wednesday 8 September to discuss the ongoing benefit-risk review of the rosiglitazone-containing medicines Avandia, Avandamet and A” View full resource at medicalnewstoday.com
Most Recently Shared on September 9, 2010 at 1:26 pm By:
MedicalNewsToday: CHMP Meets To Discuss Avandia And Pandemrix, Europe http://bit.ly/d3sOPJ Full http://bit.ly/agmp1v
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
-
MNT Drug Approvals
The latest regulatory affairs / drug approvals news published daily. Articles from research centers, universities and prestigious journals.
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
Advertisement
